ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 140 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,000 | -51.1% | 11,256 | 0.0% | 0.02% | -44.1% |
| Q2 2022 | $88,000 | -18.5% | 11,256 | -3.4% | 0.03% | 0.0% |
| Q1 2022 | $108,000 | -41.3% | 11,656 | 0.0% | 0.03% | -35.8% |
| Q4 2021 | $184,000 | -14.8% | 11,656 | -3.6% | 0.05% | -23.2% |
| Q3 2021 | $216,000 | +19.3% | 12,091 | +4.0% | 0.07% | +23.2% |
| Q2 2021 | $181,000 | +14.6% | 11,622 | +5.4% | 0.06% | +5.7% |
| Q1 2021 | $158,000 | -26.9% | 11,024 | 0.0% | 0.05% | -31.2% |
| Q4 2020 | $216,000 | +22.7% | 11,024 | -18.8% | 0.08% | +8.5% |
| Q3 2020 | $176,000 | -11.1% | 13,569 | 0.0% | 0.07% | -19.3% |
| Q2 2020 | $198,000 | +209.4% | 13,569 | +200.2% | 0.09% | +183.9% |
| Q3 2019 | $64,000 | +36.2% | 4,520 | +94.8% | 0.03% | +34.8% |
| Q2 2019 | $47,000 | – | 2,320 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |